应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00648 京玖康疗
已收盘 05-15 16:09:03
0.630
+0.090
+16.67%
最高
0.640
最低
0.540
成交量
4,139万
今开
0.540
昨收
0.540
日振幅
18.52%
总市值
13.49亿
流通市值
13.49亿
总股本
21.42亿
成交额
2,575万
换手率
1.93%
流通股本
21.42亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
京玖康疗(00648):控股股东完成配售4.45亿股公司股份
智通财经 · 33分钟前
京玖康疗(00648):控股股东完成配售4.45亿股公司股份
京玖康疗股东特别大会通过股份合并决议 5月19日正式生效
公告速递 · 40分钟前
京玖康疗股东特别大会通过股份合并决议 5月19日正式生效
京玖康疗(00648)股东将股票存入宏智证券 存仓市值1.03亿港元
智通财经 · 05-14 08:17
京玖康疗(00648)股东将股票存入宏智证券 存仓市值1.03亿港元
港股京玖康疗涨超6%
每日经济新闻 · 05-08
港股京玖康疗涨超6%
京玖康疗(00648):控股股东完成配售现有股份
智通财经 · 05-07
京玖康疗(00648):控股股东完成配售现有股份
京玖康疗4月股份变动月报:新增发行16,301,841股
公告速递 · 05-06
京玖康疗4月股份变动月报:新增发行16,301,841股
京玖康疗2026年4月股份变动月报表:增发16,301,841股
公告速递 · 05-04
京玖康疗2026年4月股份变动月报表:增发16,301,841股
京玖康疗授予董事股份购回授权,规模达已发行股本一成
公告速递 · 05-04
京玖康疗授予董事股份购回授权,规模达已发行股本一成
京玖康疗(00648)控股股东拟出售最多5亿股股份
智通财经 · 04-29
京玖康疗(00648)控股股东拟出售最多5亿股股份
京玖康疗拟“20合1”进行股份合并
新浪港股 · 04-20
京玖康疗拟“20合1”进行股份合并
京玖康疗(00648.HK)拟“20并1”并股 每手买卖单位更改为1000股合并股份
中金财经 · 04-17
京玖康疗(00648.HK)拟“20并1”并股 每手买卖单位更改为1000股合并股份
京玖康疗提议股份合并方案:每20股现有股份合并为1股
美股速递 · 04-17
京玖康疗提议股份合并方案:每20股现有股份合并为1股
京玖康疗(00648)股东将股票存入宏智证券 存仓市值2.74亿港元
智通财经 · 04-17
京玖康疗(00648)股东将股票存入宏智证券 存仓市值2.74亿港元
京玖康疗:4月1日发行约1630.18万股新股,涉资约16.30万港元
公告速递 · 04-01
京玖康疗:4月1日发行约1630.18万股新股,涉资约16.30万港元
京玖康疗(00648)完成根据特别授权发行股份
智通财经 · 04-01
京玖康疗(00648)完成根据特别授权发行股份
京玖康疗更新2026年3月股份变动月报表,股本维持不变
公告速递 · 04-01
京玖康疗更新2026年3月股份变动月报表,股本维持不变
京玖康疗(00648)发布年度业绩 年内溢利695万港元 同比减少97.87%
智通财经 · 03-27
京玖康疗(00648)发布年度业绩 年内溢利695万港元 同比减少97.87%
京玖康疗2025年:收入同比增25%,净利骤降近98%
公告速递 · 03-27
京玖康疗2025年:收入同比增25%,净利骤降近98%
京玖康疗(00648)发盈警 预期2025年亏损约4.05亿港元
智通财经 · 03-25
京玖康疗(00648)发盈警 预期2025年亏损约4.05亿港元
京玖康疗(00648.HK)拟3月27日举行董事会会议以审批年度业绩
中金财经 · 03-17
京玖康疗(00648.HK)拟3月27日举行董事会会议以审批年度业绩
暂无数据
公司概况
公司名称:
京玖康疗
所属市场:
SEHK
上市日期:
--
主营业务:
京玖医疗健康有限公司(原名:中国华仁医疗有限公司)是一家主要从事医疗保健业务的投资控股公司。该公司通过三个部门运营。医疗及健康生活业务分部从事经营肿瘤专科诊断治疗的连锁医疗中心。该分部亦从事经营眼镜产品及眼睛护理服务的连锁零售店。该分部亦从事制造及销售医药及保健相关产品。此外,该分部从事提供提供医学实验室检测服务,健康检查服务以及妇产科服务。运动及健康业务分部从事经营连锁运动及健康会所俱乐部。资产管理业务分部从事金融资产、固定资产不良资产及贷款融资。
发行价格:
--
{"stockData":{"symbol":"00648","market":"HK","secType":"STK","nameCN":"京玖康疗","latestPrice":0.63,"timestamp":1778832543769,"preClose":0.54,"halted":0,"volume":41387712,"delay":0,"changeRate":0.1666666666666666,"floatShares":2142000000,"shares":2142000000,"eps":0.012,"marketStatus":"已收盘","change":0.09,"latestTime":"05-15 16:09:03","open":0.54,"high":0.64,"low":0.54,"amount":25750472,"amplitude":0.185185,"askPrice":0.63,"askSize":395000,"bidPrice":0.62,"bidSize":110000,"shortable":0,"etf":0,"ttmEps":0.003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"listingDate":657129600000,"exchange":"SEHK","adjPreClose":0.54,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":0.361072,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00648/tweets","defaultTab":"tweets","newsList":[{"id":"2635081554","title":"京玖康疗(00648):控股股东完成配售4.45亿股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081554","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635081554?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:50","pubTimestamp":1778845805,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗 发布公告,有关公司控股股东Multi Omniverse Group Limited拟配售所持有最多4.45亿股公司股份,于2026年5月15日,公司获配售股东通知,其所持有的全部4.45亿股公司股份已由配售代理以每股配售股份0.11港元的配售价,配售予不少于6名承配人。完成配售后,配售股东于公司的权益由51.0%降至30.3%,仍为公司的控股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106358522","title":"京玖康疗股东特别大会通过股份合并决议 5月19日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1106358522","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106358522?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:42","pubTimestamp":1778845376,"startTime":"0","endTime":"0","summary":"京玖康疗发布公告称,公司于2026年5月15日举行的股东特别大会上,正式通过了股份合并相关决议案。据公告披露,截至股东特别大会召开当日,公司已发行股份总数为21.42亿股,均赋予股东出席会议并投票的权利。公告显示,股份合并将在获得联交所批准上市后,于2026年5月19日(星期二)生效,合并股份同日上午9时起开始在联交所买卖。本次股东特别大会的监票人为公司股份登记处卓佳证券登记有限公司,全体董事均出席了会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"京玖康疗股东特别大会通过股份合并决议 5月19日正式生效","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635508897","title":"京玖康疗(00648)股东将股票存入宏智证券 存仓市值1.03亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635508897","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635508897?lang=zh_cn&edition=full","pubTime":"2026-05-14 08:17","pubTimestamp":1778717840,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,5月13日,京玖康疗股东将股票存入宏智证券,存仓市值1.03亿港元,占比9.66%。京玖康疗4月29日公布,公司控股股东Multi Omniverse Group Limited已于2026年4月29日与一家配售代理订立配售协议,拟透过配售代理出售所持最多5亿股公司股份,每股配售股份0.11港元,售期自配售协议日期起至2026年5月8日止,或由配售股东与配售代理书面协定的较长期间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","161027","BK1219","00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633438731","title":"港股京玖康疗涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633438731","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633438731?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:46","pubTimestamp":1778226404,"startTime":"0","endTime":"0","summary":"5月8日,京玖康疗(00648.HK)涨超6%,截至发稿涨6.02%,报0.44港元,成交额5139.51万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605083731462050.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605083731462050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","VXUS","BK4588","BK4585","BK1511","00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128149","title":"京玖康疗(00648):控股股东完成配售现有股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128149","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633128149?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:30","pubTimestamp":1778160638,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗 发布公告,于2026年5月7日,本公司获配售股东通知,其所持有的全部5亿股本公司股份已由配售代理以每股配售股份0.11港元的配售价,配售予不少于 6名承配人。完成配售后,配售股东于本公司的权益由74.4%降至51.0%,仍为本公司的控股股东。本公司预期配售不会对本公司及其附属公司的业务运作造成任何不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1511","00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132322561","title":"京玖康疗4月股份变动月报:新增发行16,301,841股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132322561","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132322561?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:57","pubTimestamp":1778065030,"startTime":"0","endTime":"0","summary":"京玖醫療健康有限公司于2026年5月4日发布2026年4月股份变动月报表。公告显示,公司注册股本本月无变化,截至2026年4月30日,充分满足香港联交所相关公众持股量要求。本月股本结构方面,京玖康疗普通股于月初已发行股数为2,126,036,828股。报告期内,因配发及发行计划股份,新增发行16,301,841股,发行价格为每股港币0.01元。截至2026年4月30日,公司普通股已发行股份总数增加至2,142,338,669股,库藏股数量为0股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154640195","title":"京玖康疗2026年4月股份变动月报表:增发16,301,841股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154640195","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154640195?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:55","pubTimestamp":1777892143,"startTime":"0","endTime":"0","summary":"京玖康疗于2026年5月4日披露的月报显示,该公司截至2026年4月30日的已发行股份合计由上月底的2,126,036,828股增加至2,142,338,669股,共新增16,301,841股。公司本月并无库存股记载,月末已发行股份总数同样为2,142,338,669股。公司在公告中确认已满足香港联合交易所有限公司所规定的最低公众持股量要求。该公告由公司秘书林崇谦签署。公司预计将继续关注股本变动情况,并及时履行信息披露义务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101361139","title":"京玖康疗授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1101361139","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101361139?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:36","pubTimestamp":1777890980,"startTime":"0","endTime":"0","summary":"京玖康疗于公告中明确,将提请股东会授予董事会于香港联交所回购已发行股本最多10%的授权。根据最后实际可行日期时已发行2,142,338,669股股份计算,可回购上限为214,233,866股;若公司于股东大会前完成拟定的股份合并,则回购上限将同步调整为10,711,693股。董事会表示,此次回购将使用符合香港法例、上市规则及公司章程的合法资金来源,旨在提升股东回报及优化公司资本结构。董事会认为,回购计划有助于维护公司与股东的整体利益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"京玖康疗授予董事股份购回授权,规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631548312","title":"京玖康疗(00648)控股股东拟出售最多5亿股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2631548312","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631548312?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:02","pubTimestamp":1777471345,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)公布,公司控股股东 Multi Omniverse Group Limited已于 2026 年 4 月 29 日(交易时段后)与一家配售代理订立配售协议,拟透过配售代理出售所持最多5亿股公司股份,每股配售股份0.11港元,售期自配售协议日期起至 2026 年 5 月 8 日止,或由配售股东与配售代理书面协定的较长期间。于完成配售后,并假设所有配售股份均成功配售予承配人,配售股东将持有公司10.93亿股股份,相当于公司已发行股份的 51.0%,并将继续为公司的控股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","BK1219","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628793794","title":"京玖康疗拟“20合1”进行股份合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2628793794","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628793794?lang=zh_cn&edition=full","pubTime":"2026-04-20 08:17","pubTimestamp":1776644220,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 京玖康疗(00648)发布公告,公司建议按每20股现有股份合并为1股合并股份的基准进行股份合并。股份合并须待(其中包括)股东于股东特别大会上批准后方可作实。\n 于本公告日期,现有股份于联交所的每手买卖单位为每手5000股现有股份。董事会建议于股份合并生效后,将于联交所买卖的每手买卖单位由5000股现有股份更改为1000股合并股份。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-20/doc-inhvayqm8660132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00648","BK1219","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628200310","title":"京玖康疗(00648.HK)拟“20并1”并股 每手买卖单位更改为1000股合并股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628200310","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628200310?lang=zh_cn&edition=full","pubTime":"2026-04-17 22:57","pubTimestamp":1776437822,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨京玖康疗(00648.HK)公告,公司建议按每二十(20)股现有股份合并为一(1)股合并股份的基准进行股份合并。股份合并须待(其中包括)股东于股东特别大会上批准后方可作实。于本公告日期,公司已发行2,142,338,669股现有股份。倘股份合并生效,并假设自本公告日期至股份合并生效日期期间并无发行、回购并注销任何现有股份,则已发行合并股份将不少于107,116,933股。\r\n\r\n 于本公告日期,现有股份于联交所之每手买卖单位为每手5,000股现有股份。董事会建议于股份合并生效后,将于联交所买卖之每手买卖单位由5,000股现有股份更改为1,000股合并股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260417/32152787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1219","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163356141","title":"京玖康疗提议股份合并方案:每20股现有股份合并为1股","url":"https://stock-news.laohu8.com/highlight/detail?id=1163356141","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163356141?lang=zh_cn&edition=full","pubTime":"2026-04-17 22:24","pubTimestamp":1776435863,"startTime":"0","endTime":"0","summary":"京玖康疗有限公司宣布一项重大公司行动方案,计划实施股份合并操作。根据该公司披露的合并方案细则,股东持有的每20股现有普通股将合并转换为1股新的合并后股份。\n此项股份合并提案旨在优化公司股权结构,提升每股股份的市场价值表现。合并完成后,公司已发行股份总数将按比例减少,但股东所持权益比例将维持不变。该方案尚需获得公司股东大会的审议通过及相关监管机构的批准后方可实施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648","BK1219","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628228238","title":"京玖康疗(00648)股东将股票存入宏智证券 存仓市值2.74亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628228238","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628228238?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:12","pubTimestamp":1776384740,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月16日,京玖康疗(00648)股东将股票存入宏智证券,存仓市值2.74亿港元,占比44.11%。此前京玖康疗发布2025年末期业绩,该集团期内取得收益6824.3万港元,同比增加24.9%;年内溢利695万港元,同比减少97.87%;每股基本盈利0.012港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","BK1511","00648","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179068806","title":"京玖康疗:4月1日发行约1630.18万股新股,涉资约16.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179068806","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179068806?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:16","pubTimestamp":1775038596,"startTime":"0","endTime":"0","summary":"京玖康疗(股票代码:00648)于2026年4月1日发布公告,披露当日发行新股的详细情况。本次发行股数为16,301,841股,约占公司原有已发行股本的0.77%,每股发行价为0.01港元,合计涉资约16.30万港元。\n本次发行完成后,公司已发行股本由2,126,036,828股增至2,142,338,669股。公告亦显示,该次股份发行已获得董事会批准,公司确认已遵守香港联交所证券上市规则及相关法律法规。\n本公告由公司秘书林崇谦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594652","title":"京玖康疗(00648)完成根据特别授权发行股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594652","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624594652?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:09","pubTimestamp":1775038160,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布公告,有关发行计划股份的先决条件均已达成,并已于2026年4月1日完成发行计划股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173465742","title":"京玖康疗更新2026年3月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1173465742","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173465742?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:02","pubTimestamp":1775037738,"startTime":"0","endTime":"0","summary":"京玖医疗健康有限公司(京玖康疗,股票代码:00648)于2026年4月1日发布2026年3月股份变动月报表。报告显示,截至2026年3月31日,公司普通股总数维持在2,126,036,828股,库存股份为0股,股本结构与上月相比并无新增发行、购回或注销活动。\n报告期内,公司未涉及任何股份期权、权证及可换股票据的增发或行使,也无其他类型的股份变动。公司同时确认其公众持股比例符合相关上市规则的最低门槛要求。\n上述信息已获公司董事会正式授权。公司表示将继续遵守香港联交所《上市规则》及其他适用法律法规的规定。本次公告由公司秘书林崇谦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622082873","title":"京玖康疗(00648)发布年度业绩 年内溢利695万港元 同比减少97.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082873","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622082873?lang=zh_cn&edition=full","pubTime":"2026-03-27 23:07","pubTimestamp":1774624031,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布2025年末期业绩,该集团期内取得收益6824.3万港元,同比增加24.9%;年内溢利695万港元,同比减少97.87%;每股基本盈利0.012港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"京玖康疗(00648)发布年度业绩 年内溢利695万港元 同比减少97.87%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147256702","title":"京玖康疗2025年:收入同比增25%,净利骤降近98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147256702","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147256702?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:17","pubTimestamp":1774621073,"startTime":"0","endTime":"0","summary":"京玖康疗于截至2025年12月31日止年度录得收入6,824.30万元,同比上年度的5,463.90万元增长25%。同期内,年度溢利及全面收益总额为695.00万元,较2024年度的32,631.70万元大幅下降97.9%,主要因上一年度获得按公平值计入损益之金融资产的显著收益,而本期仅录得少量债务重组收益。该集团主营通过医疗及保健设备及产品的分销开展业务,当期毛利为2,259.30万元,同比增加23%,毛利率略降至33.1%。期内所得税开支249.80万元,较上年度增加53%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622787620","title":"京玖康疗(00648)发盈警 预期2025年亏损约4.05亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622787620","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622787620?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:51","pubTimestamp":1774439494,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布公告,由于以实物形式偿还债务产生公平值亏损约4.12亿港元,预期本集团截至2025年12月31日止年度将录得重大亏损约4.05亿港元。该公平值亏损源自本公司于2025年11月11日为偿还贷款而发行的18亿股新股份,其发行价每股0.01港元与同日收市价每股0.239港元之间的差额所致。此公平值亏损属一次性及非现金性质,仅影响本集团的损益表及权益变动表,对本集团的资产负债表、现金流及资产净值并无影响。若撇除特殊项目,本集团于其日常业务过程中将录得溢利约1000万港元,而2024年的溢利(撇除特殊项目)则为690万港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"京玖康疗(00648)发盈警 预期2025年亏损约4.05亿港元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1511","00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620942600","title":"京玖康疗(00648.HK)拟3月27日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620942600","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620942600?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:07","pubTimestamp":1773745625,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨京玖康疗(00648.HK)公告,将于2026年3月27日(星期五)举行董事会会议,以批准刊发本公司及其附属公司截至2025年12月31日年度业绩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32075420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1511","00648","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinawahyan.com","stockEarnings":[{"period":"1week","weight":0.3012},{"period":"1month","weight":0.8621},{"period":"3month","weight":1.8877},{"period":"6month","weight":1.5714},{"period":"1year","weight":0.2273},{"period":"ytd","weight":1.9032}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":0.02},{"period":"3month","weight":-0.0067},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1163},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"京玖医疗健康有限公司(原名:中国华仁医疗有限公司)是一家主要从事医疗保健业务的投资控股公司。该公司通过三个部门运营。医疗及健康生活业务分部从事经营肿瘤专科诊断治疗的连锁医疗中心。该分部亦从事经营眼镜产品及眼睛护理服务的连锁零售店。该分部亦从事制造及销售医药及保健相关产品。此外,该分部从事提供提供医学实验室检测服务,健康检查服务以及妇产科服务。运动及健康业务分部从事经营连锁运动及健康会所俱乐部。资产管理业务分部从事金融资产、固定资产不良资产及贷款融资。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.954796},{"month":2,"riseRate":0.615385,"avgChangeRate":0.079973},{"month":3,"riseRate":0.32,"avgChangeRate":-0.040357},{"month":4,"riseRate":0.5,"avgChangeRate":0.069738},{"month":5,"riseRate":0.538462,"avgChangeRate":0.103515},{"month":6,"riseRate":0.24,"avgChangeRate":-0.077994},{"month":7,"riseRate":0.32,"avgChangeRate":-0.013407},{"month":8,"riseRate":0.12,"avgChangeRate":-0.084593},{"month":9,"riseRate":0.4,"avgChangeRate":0.019004},{"month":10,"riseRate":0.52,"avgChangeRate":-0.021538},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.042928},{"month":12,"riseRate":0.24,"avgChangeRate":-0.034829}],"exchange":"SEHK","name":"京玖康疗","nameEN":"SOFTMEDX"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"京玖康疗(00648)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供京玖康疗(00648)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"京玖康疗,00648,京玖康疗股票,京玖康疗股票老虎,京玖康疗股票老虎国际,京玖康疗行情,京玖康疗股票行情,京玖康疗股价,京玖康疗股市,京玖康疗股票价格,京玖康疗股票交易,京玖康疗股票购买,京玖康疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"京玖康疗(00648)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供京玖康疗(00648)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}